CNBX Pharmaceuticals Inc. Quarterly General and Administrative Expense in USD from Q4 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual General and Administrative Expense history and growth rate from Q4 2010 to Q4 2024.
  • CNBX Pharmaceuticals Inc. General and Administrative Expense for the quarter ending November 30, 2024 was $36.8K, a 75.3% decline year-over-year.
  • CNBX Pharmaceuticals Inc. General and Administrative Expense for the twelve months ending November 30, 2024 was $406K, a 47.6% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual General and Administrative Expense for 2024 was $518K, a 43% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual General and Administrative Expense for 2023 was $910K, a 49.5% decline from 2022.
  • CNBX Pharmaceuticals Inc. annual General and Administrative Expense for 2022 was $1.8M, a 117% increase from 2021.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $406K $36.8K -$112K -75.3% Sep 1, 2024 Nov 30, 2024 10-Q 2025-01-13
Q3 2024 $518K $126K -$41.8K -24.8% Jun 1, 2024 Aug 31, 2024 10-K 2024-11-29
Q2 2024 $560K $109K -$111K -50.3% Mar 1, 2024 May 31, 2024 10-Q 2024-07-15
Q1 2024 $671K $134K -$104K -43.8% Dec 1, 2023 Feb 29, 2024 10-Q 2024-04-16
Q4 2023 $775K $149K -$135K -47.5% Sep 1, 2023 Nov 30, 2023 10-Q 2025-01-13
Q3 2023 $910K $168K -$176K -51.2% Jun 1, 2023 Aug 31, 2023 10-K 2024-11-29
Q2 2023 $1.09M $220K -$166K -43% Mar 1, 2023 May 31, 2023 10-Q 2024-07-15
Q1 2023 $1.25M $238K -$162K -40.5% Dec 1, 2022 Feb 28, 2023 10-Q 2024-04-16
Q4 2022 $1.41M $284K -$386K -57.6% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-12
Q3 2022 $1.8M $345K +$212K +159% Jun 1, 2022 Aug 31, 2022 10-K 2023-11-30
Q2 2022 $1.59M $386K +$261K +208% Mar 1, 2022 May 31, 2022 10-Q 2023-07-14
Q1 2022 $1.33M $400K +$47.8K +13.6% Dec 1, 2021 Feb 28, 2022 10-Q 2023-04-14
Q4 2021 $1.28M $670K +$452K +207% Sep 1, 2021 Nov 30, 2021 10-Q 2023-01-13
Q3 2021 $829K $133K -$103K -43.7% Jun 1, 2021 Aug 31, 2021 10-K 2022-11-30
Q2 2021 $932K $125K -$197K -61.1% Mar 1, 2021 May 31, 2021 10-Q 2022-07-14
Q1 2021 $1.13M $352K -$71.4K -16.9% Dec 1, 2020 Feb 28, 2021 10-Q 2022-04-12
Q4 2020 $1.2M $218K -$108K -33.1% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-13
Q3 2020 $1.31M $236K -$41.4K -14.9% Jun 1, 2020 Aug 31, 2020 10-K 2021-11-29
Q2 2020 $1.35M $322K -$126K -28% Mar 1, 2020 May 31, 2020 10-Q 2021-07-14
Q1 2020 $1.48M $423K -$47.1K -10% Dec 1, 2019 Feb 29, 2020 10-Q 2021-04-14
Q4 2019 $1.52M $326K +$40.7K +14.2% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-14
Q3 2019 $1.48M $277K +$125K +81.7% Jun 1, 2019 Aug 31, 2019 10-K 2020-11-04
Q2 2019 $1.36M $448K -$143K -24.2% Mar 1, 2019 May 31, 2019 10-Q 2020-07-14
Q1 2019 $1.5M $470K -$989K -67.8% Dec 1, 2018 Feb 28, 2019 10-Q 2020-04-13
Q4 2018 $2.49M $286K +$96.4K +50.9% Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-14
Q3 2018 $2.39M $153K -$558K -78.5% Jun 1, 2018 Aug 31, 2018 10-K 2019-11-29
Q2 2018 $2.95M $591K +$200K +51.1% Mar 1, 2018 May 31, 2018 10-Q 2019-07-15
Q1 2018 $2.75M $1.46M +$1.32M +923% Dec 1, 2017 Feb 28, 2018 10-Q 2019-04-15
Q4 2017 $1.43M $189K +$109K +135% Sep 1, 2017 Nov 30, 2017 10-Q 2019-01-17
Q3 2017 $1.33M $711K +$639K +896% Jun 1, 2017 Aug 31, 2017 10-K 2018-11-29
Q2 2017 $686K $391K +$343K +710% Mar 1, 2017 May 31, 2017 10-Q 2018-07-16
Q1 2017 $343K $143K +$91.7K +180% Dec 1, 2016 Feb 28, 2017 10-Q 2018-04-05
Q4 2016 $251K $80.7K +$36.7K +83.3% Sep 1, 2016 Nov 30, 2016 10-Q 2018-01-16
Q3 2016 $215K $71.4K -$157K -68.7% Jun 1, 2016 Aug 31, 2016 10-K 2017-12-08
Q2 2016 $371K $48.3K -$14.5K -23.1% Mar 1, 2016 May 31, 2016 10-Q 2017-07-17
Q1 2016 $386K $50.9K +$31.7K +165% Dec 1, 2015 Feb 29, 2016 10-Q 2017-04-14
Q4 2015 $354K $44K +$19.7K +80.8% Sep 1, 2015 Nov 30, 2015 10-Q 2017-01-17
Q3 2015 $334K $228K +$403K Jun 1, 2015 Aug 31, 2015 10-K 2016-12-13
Q2 2015 -$69K $62.8K -$151K -70.6% Mar 1, 2015 May 31, 2015 10-Q 2016-07-13
Q1 2015 $82.2K $19.2K +$18.1K +1687% Dec 1, 2014 Feb 28, 2015 10-Q 2016-04-18
Q4 2014 $64K $24.4K +$23.6K +3016% Sep 1, 2014 Nov 30, 2014 10-Q/A 2016-04-08
Q3 2014 $40.4K -$175K Jun 1, 2014 Aug 31, 2014 10-K 2016-01-07
Q2 2014 $214K +$214K Mar 1, 2014 May 31, 2014 10-Q/A 2015-11-17
Q1 2014 $1.08K Dec 1, 2013 Feb 28, 2014 10-Q/A 2015-11-17
Q4 2013 $782 +$682 Sep 1, 2013 Nov 30, 2013 10-Q/A 2015-11-17
Q2 2013 $0 Mar 1, 2013 May 31, 2013 10-Q/A 2014-07-15
Q4 2012 $100* Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q4 2010 $148* Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.